Literature DB >> 25938360

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

P N A Harris1, L Alder, D L Paterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25938360     DOI： 10.1097/PAT.0000000000000255

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

Review 1.  A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Authors:  Pranita D Tamma; Yohei Doi; Robert A Bonomo; J Kristie Johnson; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

2.  Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.

Authors:  Lucy Cheng; Brian C Nelson; Monica Mehta; Nikhil Seval; Sarah Park; Marla J Giddins; Qiuhu Shi; Susan Whittier; Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.

Authors:  Patrick N A Harris; Anna M Peri; Anita M Pelecanos; Carly M Hughes; David L Paterson; John K Ferguson
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-21       Impact factor: 4.887

4.  Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Authors:  Pranita D Tamma; Sima L Sharara; Zoi D Pana; Joe Amoah; Stephanie L Fisher; Tsigereda Tekle; Yohei Doi; Patricia J Simner
Journal:  Open Forum Infect Dis       Date:  2019-08-11       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.